Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2021 Filed Oct 1, 2021 20:12 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.74 | $18,700.00 |
DisclosureSEC source: 0001593968-21-002214 · primary_01.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2021 Filed Feb 15, 2022 00:33 UTC |
Flynn Sean C.VP, General Counsel
|
GrantCommon Stock | 145 | $41.48 | $6,014.60 |
DisclosureSEC source: 0001593968-22-000467 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,564 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,200 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 7,200 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC |
Flynn Sean C.VP, General Counsel
|
SaleCommon Stock | 7,200 | $55.11 | $396,760.32 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:10 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionCommon Stock | 7,200 | $16.25 | $117,000.00 |
DisclosureSEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-21-001986 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,063 Underlying: Common Stock · 15,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:05 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 15,000 | $48.03 | $720,480.00 |
DisclosureSEC source: 0001593968-21-001986 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,623 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:05 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 15,000 | $2.65 | $39,750.00 |
DisclosureSEC source: 0001593968-21-001986 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,800 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,200 Underlying: Common Stock · 2,800 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC |
Flynn Sean C.VP, General Counsel
|
SaleCommon Stock | 2,800 | $55.01 | $154,028.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:04 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionCommon Stock | 2,800 | $16.25 | $45,500.00 |
DisclosureSEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · derivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 10,000 shares Expires 2029-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC |
Flynn Sean C.VP, General Counsel
|
SaleCommon Stock | 10,000 | $51.18 | $511,786.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:07 UTC |
Flynn Sean C.VP, General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $16.25 | $162,500.00 |
DisclosureSEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:13 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-21-001838 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,063 Underlying: Common Stock · 20,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:13 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 20,000 | $53.54 | $1,070,876.00 |
DisclosureSEC source: 0001593968-21-001838 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,623 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2021. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:13 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 20,000 | $2.65 | $53,000.00 |
DisclosureSEC source: 0001593968-21-001838 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:20 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 694 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001593968-21-001776 · primary_01.xml · derivative · entry 3 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,604 Underlying: Common Stock · 694 shares Expires 2028-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:20 UTC |
Hopper Jonathan MarkChief Medical Officer
|
SaleCommon Stock | 134 | $57.14 | $7,656.77 |
DisclosureSEC source: 0001593968-21-001776 · primary_01.xml · nonDerivative · entry 2 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,319 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:20 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionCommon Stock | 694 | $10.95 | $7,599.30 |
DisclosureSEC source: 0001593968-21-001776 · primary_01.xml · nonDerivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:14 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,000 | $52.50 | $210,000.00 |
DisclosureSEC source: 0001593968-21-001772 · primary_01.xml · derivative · entry 3 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 25, 2021. The remaining RSUs will vest in quarterly installments on September 30, 2021, and December 31, 2021, respectively. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:14 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
Tax withholdingCommon Stock | 1,174 | $52.50 | $61,635.00 |
DisclosureSEC source: 0001593968-21-001772 · primary_01.xml · nonDerivative · entry 2 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,848 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:14 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
Exercise / conversionCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001772 · primary_01.xml · nonDerivative · entry 1 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on January 25, 2021. The remaining RSUs will vest in quarterly installments on September 30, 2021, and December 31, 2021, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC |
WRIGHT LISADirector
|
GrantRestricted Stock Unit · Derivative | 2,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs shall vest on the earlier of June 1, 2022 or the date of the Company's next annual meeting of shareholders, contingent upon continued service to the Company. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC |
WRIGHT LISADirector
|
GrantStock Option (right to buy) · Derivative | 5,877 | $0.00 Strike: $56.49 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,877 Underlying: Common Stock · 5,877 shares Expires 2031-06-01 F5 · derivative.exercise_date: These options, representing the right to purchase a total of 5,877 shares, shall vest and become exercisable in equal monthly installments beginning on June 1, 2021, and shall become fully vested and exercisable on the earlier of the date of the Company's next annual meeting of shareholders or April 27, 2022, contingent upon continued service to the Company. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC |
WRIGHT LISADirector
|
GrantStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $56.49 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock · 3,250 shares Expires 2031-06-01 F4 · derivative.exercise_date: These options, representing the right to purchase a total of 3,250 shares, shall vest and become exercisable in equal monthly installments over three years, beginning on June 1, 2021, contingent upon continued service to the Company. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC |
WRIGHT LISADirector
|
GrantRestricted Stock Unit · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · derivative · entry 6 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase a total of 3,000 shares, became exercisable in equal monthly installments over one year, beginning on May 7, 2014, contingent upon continued service to the Company. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · derivative · entry 5 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2023-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 2,250 shares, became exercisable in equal monthly installments over nine months, beginning on August 23, 2013, contingent upon continued service to the Company. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · derivative · entry 4 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2023-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 1,500 shares, became exercisable in equal monthly installments over one year, beginning on August 23, 2013, contingent upon continued service to the Company. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 2,250 | $6.00 | $13,500.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · nonDerivative · entry 3 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 3,000 | $4.12 | $12,360.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · nonDerivative · entry 2 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:10 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 1,500 | $6.00 | $9,000.00 |
DisclosureSEC source: 0001593968-21-001389 · primary_01.xml · nonDerivative · entry 1 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:39 UTC |
Wotton Paul KDirector
|
SaleCommon Stock | 5,000 | $50.52 | $252,611.00 |
DisclosureSEC source: 0001593968-21-001334 · primary_01.xml · nonDerivative · entry 1 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,602 F1 · shares: These shares were sold by the Reporting Person following the exercises and sales reported on May 13, 2021. The Reporting Person has elected to hold all remaining shares at this time. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
SaleCommon Stock | 2,200 | $48.88 | $107,533.58 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · nonDerivative · entry 5 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,602 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · derivative · entry 8 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 13,125 shares, became exercisable in equal monthly installments over one year, beginning on May 1, 2019, contingent upon continued service to the Company. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · derivative · entry 7 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,125 shares Expires 2030-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 13,125 shares, became exercisable in equal monthly installments over one year, beginning on April 29, 2020, contingent upon continued service to the Company. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · derivative · entry 6 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options, representing the right to purchase a total of 17,500 shares, became exercisable in equal monthly installments over one year, beginning on May 2, 2018, contingent upon continued service to the Company. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
SaleCommon Stock | 13,448 | $50.11 | $673,922.31 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · nonDerivative · entry 4 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,802 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionCommon Stock | 13,125 | $16.62 | $218,137.50 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · nonDerivative · entry 3 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionCommon Stock | 13,125 | $14.56 | $191,100.00 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · nonDerivative · entry 2 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:50 UTC |
Wotton Paul KDirector
|
Exercise / conversionCommon Stock | 17,500 | $13.05 | $228,375.00 |
DisclosureSEC source: 0001593968-21-001317 · primary_01.xml · nonDerivative · entry 1 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:10 UTC |
Rubino Alan LDirector
|
GrantRestricted Stock Unit · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001211 · primary_01.xml · derivative · entry 4 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:10 UTC |
Rubino Alan LDirector
|
GrantStock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $63.22 | $0.00 |
DisclosureSEC source: 0001593968-21-001211 · primary_01.xml · derivative · entry 3 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2031-04-28 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:10 UTC |
Rubino Alan LDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001211 · primary_01.xml · derivative · entry 2 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. The first Annual Meeting of Stockholders occurred on April 28, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:10 UTC |
Rubino Alan LDirector
|
Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001211 · primary_01.xml · nonDerivative · entry 1 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on April 29, 2020. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantRestricted Stock Unit · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001210 · primary_01.xml · derivative · entry 4 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $63.22 | $0.00 |
DisclosureSEC source: 0001593968-21-001210 · primary_01.xml · derivative · entry 3 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2031-04-28 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001210 · primary_01.xml · derivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2021 or the date of the first Annual Meeting of Stockholders following April 29, 2020. The first Annual Meeting of Stockholders occurred on April 28, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001210 · primary_01.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on April 29, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.